📊 Evidence-Based Reference

Gore Dryseal Sheath

W. L. Gore & Associates, Inc.

Contact W. L. Gore & Associates, Inc. ↗ Compare similar devices

Summary: The Gore DrySeal Sheath is a vascular access device used primarily in complex percutaneous interventions. Key evidence highlights its utility in facilitating transcatheter procedures, especially in challenging anatomical scenarios.

FDA Clearance Information

Pathway ? 510(k)
Number ? K093791 ↗
Decision Date ? March 22, 2010
Product Code ? DYB
Device Class ? Class 2
Evidence ? 0 studies

The Gore DrySeal Sheath was cleared by the FDA via the 510(k) pathway on March 22, 2010. It is manufactured by W.L. Gore & Associates and is classified as a Class 2 medical device.

What It Is

The Gore DrySeal Sheath is designed to provide a stable and secure vascular access during endovascular procedures. It features a hemostatic valve to minimize blood loss and is used to facilitate the introduction of various interventional devices.

FDA-Cleared Indications

  • Access to the vascular system for the introduction of diagnostic or interventional devices.
  • Maintaining vascular access during endovascular procedures.
  • Use with compatible intravascular devices in procedures requiring a hemostatic valve and large-bore access.

Clinical Applications

  • Providing vascular access for endovascular device introduction.
  • Maintaining access during catheter-based vascular interventions.
  • Facilitating procedures in which repeated device exchanges are required through a stable sheath.
  • Providing hemostatic access during procedures that use compatible large-diameter catheters or delivery systems.

Reported off-label uses

  • Use as an access sheath for selected embolization procedures when the sheath size and device compatibility are appropriate.
  • Use for complex arterial or venous interventions not specifically described in the device labeling, based on operator judgment and institutional practice.

Off-label use: these uses are reported in practice or the literature but are not part of the FDA-cleared indications. Physicians may use a cleared device off-label based on their medical judgment; the manufacturer may not promote off-label uses.

Evidence Summary

The literature includes six studies ranging from 2020 to 2025, comprising case series and retrospective analyses. These studies explore the sheath's role in facilitating transcatheter procedures and its impact on procedural success.

Reported Outcomes

Published studies report that the Gore DrySeal Sheath effectively facilitates device delivery in complex vascular procedures, particularly in cases with severe tortuosity or calcification. It has been shown to improve procedural success rates in transcatheter pulmonary valve implantation and other interventions.

Safety Profile

Reported complications include potential vascular injury due to large sheath size and challenges in patients with severe vascular tortuosity. However, the sheath's design aims to minimize such risks by providing a stable access point.

Evidence Limitations

Current evidence is limited by the small sample sizes and retrospective nature of most studies. Further prospective research is needed to fully understand the long-term safety and efficacy of the Gore DrySeal Sheath in diverse patient populations.

Practical Considerations

  • Available sizes and lengths vary by model; the sheath must match the planned catheter, delivery system, guidewire, and vessel diameter.
  • The access site and sheath size should be selected after considering vessel caliber, tortuosity, calcification, thrombosis risk, and the need for hemostasis.
  • Use fluoroscopic or other appropriate imaging guidance and follow the manufacturer's instructions for insertion, flushing, device exchange, and removal.
  • Potential complications include bleeding, hematoma, vessel injury, thrombosis, embolization, infection, and distal ischemia.
  • The sheath itself is not the component being imaged by MRI; MRI safety depends on the specific model, whether it remains in place, and the manufacturer's current labeling. Confirm conditions before MRI.

Procedures that use this device

Frequently Asked Questions

What are the clinical indications for Gore DrySeal Sheath?

The Gore DrySeal Sheath is indicated for use in endovascular procedures requiring large-bore vascular access, such as transcatheter valve replacements.

What outcomes have been reported in clinical studies?

Studies report improved procedural success rates in complex interventions, particularly in cases with challenging vascular anatomy.

What complications have been reported?

Safety data indicate potential vascular injury risks, especially in patients with severe tortuosity, but the sheath's design helps mitigate these issues.

Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference. It does not constitute medical advice, product endorsement, or a recommendation for clinical use. Always consult manufacturer documentation and clinical judgment for patient care decisions.

📬 The IR Device Brief

One email a month: new FDA clearances, recalls and device pages in vascular & interventional radiology.

We'll email you a link to confirm. Unsubscribe any time.

Suggest edits

For manufacturers and their teams. Each field shows what the page says now: add, remove or rewrite anything, and leave the rest as is. LA Vascular reviews every change before it goes live.

About you